Shehab, H. M., & Yasmin, H. (2024). A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine. Brac University.
शिकागो शैली (17वां संस्करण) प्रशस्ति पत्रShehab, Habibul Mohsin, और Hasina Yasmin. A Pharmacovigilance Study to Determine Risk of Mortality in Male and Female Patients with Alzheimer's Disease Using Rivastigmine. Brac University, 2024.
एमएलए (8वां संस्करण) प्रशस्ति पत्रShehab, Habibul Mohsin, और Hasina Yasmin. A Pharmacovigilance Study to Determine Risk of Mortality in Male and Female Patients with Alzheimer's Disease Using Rivastigmine. Brac University, 2024.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.